Quote | Astria Therapeutics Inc. (NASDAQ:ATXS)
Last: | $11.20 |
---|---|
Change Percent: | -0.72% |
Open: | $11.13 |
Close: | $11.20 |
High: | $11.43 |
Low: | $10.93 |
Volume: | 488,532 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Astria Therapeutics Inc. (NASDAQ:ATXS)
2024-06-24 01:43:14 ET Summary Astria Therapeutics stock has fallen 40% since early 2023, but promising early data for its candidate STAR-0215 in treating HAE is helping drive analyst Buy ratings. ATXS stock has a compound called STAR-0310 in development for an immune disorder, wi...
2024-06-16 18:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Astria Therapeutics Inc. (NASDAQ:ATXS)
Subject | By | Source | When |
---|---|---|---|
znewcar1: ATXS was CATB | znewcar1 | investorshangout | 09/15/2021 8:37:25 PM |
znewcar1: CATB 70% v286M c4.15 f20,0M H7.97 S3.82 | znewcar1 | investorshangout | 01/29/2021 10:03:03 PM |
whytestocks: $CATB News Article - 3 Biotech Penny Stocks to Watch as February Approaches | whytestocks | investorshangout | 01/29/2021 3:35:52 PM |
znewcar1: CATB 28% v197M c2.09 f20,0M H3.25 S2 | znewcar1 | investorshangout | 12/02/2020 9:17:01 PM |
whytestocks: $CATB News Article - Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor | whytestocks | investorshangout | 09/08/2020 4:35:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Astria Therapeutics Inc. Company Name:
ATXS Stock Symbol:
NASDAQ Market:
Astria Therapeutics Inc. Website:
2024-06-16 18:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present final STAR-0215 Phase 1a healthy subject data in an encore presentation at the upcoming Eastern Allerg...
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Va...